Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine
Gespeichert in:
| Veröffentlicht in: | Depression and anxiety 2002, Vol.16 (3), p.89-92 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 92 |
|---|---|
| container_issue | 3 |
| container_start_page | 89 |
| container_title | Depression and anxiety |
| container_volume | 16 |
| creator | Shytle, R. Douglas Silver, Archie A. Sheehan, Kathy H. Sheehan, David V. Sanberg, Paul R. |
| description | |
| doi_str_mv | 10.1002/da.10035 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72637148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21201722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4515-3f16581cd0430f9a97a2cf804473b29c578c574fef62fb7e4bd2664ed7279a7e3</originalsourceid><addsrcrecordid>eNqN0U9vFCEYBvCJ0dhaTfwEhpPxMsrfYTg2rV1Na43Jmh4JAy8WnRlWYG3328u6Wz01lQReSH55DjxN85LgtwRj-s6Z7WTiUXNIBMVtxxR_XO9YkZbTTh00z3L-jjHuVY-fNgeEciIEI4dNuYR1irMZ0RxsLKGeKIGFVYkJhfk6DKGEOCNfnyWBqeIbmmJ0yIUck4OU0SrBGKYwm7RBNs4lxXEEh-BXcDBbQDehXKMJrJk2o6kOnjdPvBkzvNjPo-br2fvlyYf24vPi48nxRWu5IKJlnnSiJ9ZhzrBXRklDre8x55INVFkh-7q5B99RP0jgg6Ndx8FJKpWRwI6a17vcVYo_15CLnkK2MI5mhrjOWtKOScL7ByElFBNJ6X_Aupjawjc7aFPMOYHXqxSm-kOaYL3tTDuj_3RW6at95nqYwP2D-5IqaHfgJoywuTdInx7fBe59yAVu_3qTfuhOMin01eVCi-WX06vlp4U-Z78BZaywXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21111392</pqid></control><display><type>article</type><title>Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Shytle, R. Douglas ; Silver, Archie A. ; Sheehan, Kathy H. ; Sheehan, David V. ; Sanberg, Paul R.</creator><creatorcontrib>Shytle, R. Douglas ; Silver, Archie A. ; Sheehan, Kathy H. ; Sheehan, David V. ; Sanberg, Paul R.</creatorcontrib><identifier>ISSN: 1091-4269</identifier><identifier>EISSN: 1520-6394</identifier><identifier>DOI: 10.1002/da.10035</identifier><identifier>PMID: 12415531</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Attention Deficit Disorder with Hyperactivity - psychology ; Child ; Depressive Disorder, Major - drug therapy ; Depressive Disorder, Major - etiology ; Double-Blind Method ; Female ; Humans ; Male ; Mecamylamine - pharmacology ; Mecamylamine - therapeutic use ; Neurons - drug effects ; Nicotinic Antagonists - pharmacology ; Nicotinic Antagonists - therapeutic use ; Receptors, Nicotinic - drug effects ; Tourette Syndrome - psychology</subject><ispartof>Depression and anxiety, 2002, Vol.16 (3), p.89-92</ispartof><rights>Copyright © 2002 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4515-3f16581cd0430f9a97a2cf804473b29c578c574fef62fb7e4bd2664ed7279a7e3</citedby><cites>FETCH-LOGICAL-c4515-3f16581cd0430f9a97a2cf804473b29c578c574fef62fb7e4bd2664ed7279a7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fda.10035$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fda.10035$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4010,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12415531$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shytle, R. Douglas</creatorcontrib><creatorcontrib>Silver, Archie A.</creatorcontrib><creatorcontrib>Sheehan, Kathy H.</creatorcontrib><creatorcontrib>Sheehan, David V.</creatorcontrib><creatorcontrib>Sanberg, Paul R.</creatorcontrib><title>Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine</title><title>Depression and anxiety</title><addtitle>Depress. Anxiety</addtitle><subject>Adolescent</subject><subject>Attention Deficit Disorder with Hyperactivity - psychology</subject><subject>Child</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Depressive Disorder, Major - etiology</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Mecamylamine - pharmacology</subject><subject>Mecamylamine - therapeutic use</subject><subject>Neurons - drug effects</subject><subject>Nicotinic Antagonists - pharmacology</subject><subject>Nicotinic Antagonists - therapeutic use</subject><subject>Receptors, Nicotinic - drug effects</subject><subject>Tourette Syndrome - psychology</subject><issn>1091-4269</issn><issn>1520-6394</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0U9vFCEYBvCJ0dhaTfwEhpPxMsrfYTg2rV1Na43Jmh4JAy8WnRlWYG3328u6Wz01lQReSH55DjxN85LgtwRj-s6Z7WTiUXNIBMVtxxR_XO9YkZbTTh00z3L-jjHuVY-fNgeEciIEI4dNuYR1irMZ0RxsLKGeKIGFVYkJhfk6DKGEOCNfnyWBqeIbmmJ0yIUck4OU0SrBGKYwm7RBNs4lxXEEh-BXcDBbQDehXKMJrJk2o6kOnjdPvBkzvNjPo-br2fvlyYf24vPi48nxRWu5IKJlnnSiJ9ZhzrBXRklDre8x55INVFkh-7q5B99RP0jgg6Ndx8FJKpWRwI6a17vcVYo_15CLnkK2MI5mhrjOWtKOScL7ByElFBNJ6X_Aupjawjc7aFPMOYHXqxSm-kOaYL3tTDuj_3RW6at95nqYwP2D-5IqaHfgJoywuTdInx7fBe59yAVu_3qTfuhOMin01eVCi-WX06vlp4U-Z78BZaywXg</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Shytle, R. Douglas</creator><creator>Silver, Archie A.</creator><creator>Sheehan, Kathy H.</creator><creator>Sheehan, David V.</creator><creator>Sanberg, Paul R.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine</title><author>Shytle, R. Douglas ; Silver, Archie A. ; Sheehan, Kathy H. ; Sheehan, David V. ; Sanberg, Paul R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4515-3f16581cd0430f9a97a2cf804473b29c578c574fef62fb7e4bd2664ed7279a7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Attention Deficit Disorder with Hyperactivity - psychology</topic><topic>Child</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Depressive Disorder, Major - etiology</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Mecamylamine - pharmacology</topic><topic>Mecamylamine - therapeutic use</topic><topic>Neurons - drug effects</topic><topic>Nicotinic Antagonists - pharmacology</topic><topic>Nicotinic Antagonists - therapeutic use</topic><topic>Receptors, Nicotinic - drug effects</topic><topic>Tourette Syndrome - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shytle, R. Douglas</creatorcontrib><creatorcontrib>Silver, Archie A.</creatorcontrib><creatorcontrib>Sheehan, Kathy H.</creatorcontrib><creatorcontrib>Sheehan, David V.</creatorcontrib><creatorcontrib>Sanberg, Paul R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Depression and anxiety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shytle, R. Douglas</au><au>Silver, Archie A.</au><au>Sheehan, Kathy H.</au><au>Sheehan, David V.</au><au>Sanberg, Paul R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine</atitle><jtitle>Depression and anxiety</jtitle><addtitle>Depress. Anxiety</addtitle><date>2002</date><risdate>2002</risdate><volume>16</volume><issue>3</issue><spage>89</spage><epage>92</epage><pages>89-92</pages><issn>1091-4269</issn><eissn>1520-6394</eissn><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>12415531</pmid><doi>10.1002/da.10035</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1091-4269 |
| ispartof | Depression and anxiety, 2002, Vol.16 (3), p.89-92 |
| issn | 1091-4269 1520-6394 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72637148 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | Adolescent Attention Deficit Disorder with Hyperactivity - psychology Child Depressive Disorder, Major - drug therapy Depressive Disorder, Major - etiology Double-Blind Method Female Humans Male Mecamylamine - pharmacology Mecamylamine - therapeutic use Neurons - drug effects Nicotinic Antagonists - pharmacology Nicotinic Antagonists - therapeutic use Receptors, Nicotinic - drug effects Tourette Syndrome - psychology |
| title | Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T05%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuronal%20nicotinic%20receptor%20inhibition%20for%20treating%20mood%20disorders%20preliminary%20controlled%20evidence%20with%20mecamylamine&rft.jtitle=Depression%20and%20anxiety&rft.au=Shytle,%20R.%20Douglas&rft.date=2002&rft.volume=16&rft.issue=3&rft.spage=89&rft.epage=92&rft.pages=89-92&rft.issn=1091-4269&rft.eissn=1520-6394&rft_id=info:doi/10.1002/da.10035&rft_dat=%3Cproquest_cross%3E21201722%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21111392&rft_id=info:pmid/12415531&rfr_iscdi=true |